UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Outperform Votes

Underperform Votes

Community Sentiment

UnitedHealth Group has received 68.41% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about UnitedHealth Group and other stocks. Vote “Outperform” if you believe UNH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe UNH will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.0 Company Ownership

In the past three months, UnitedHealth Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,723,013.00 in company stock.

Miscellaneous

Receive UNH News and Ratings via Email

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

UnitedHealth Group (NYSE:UNH) Frequently Asked Questions

How has UnitedHealth Group's stock been impacted by COVID-19 (Coronavirus)?

UnitedHealth Group's stock was trading at $277.78 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, UNH shares have increased by 12.3% and is now trading at $311.85. View which stocks have been most impacted by Coronavirus.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 3 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for UnitedHealth Group.

When is UnitedHealth Group's next earnings date?

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Inc (NYSE:UNH) posted its earnings results on Wednesday, April, 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, topping the consensus estimate of $3.63 by $0.09. The healthcare conglomerate had revenue of $64.40 billion for the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a return on equity of 24.86% and a net margin of 5.59%. The business's revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.73 earnings per share. View UnitedHealth Group's earnings history.

How often does UnitedHealth Group pay dividends? What is the dividend yield for UnitedHealth Group?

UnitedHealth Group declared a quarterly dividend on Wednesday, June 3rd. Stockholders of record on Monday, June 22nd will be given a dividend of $1.25 per share on Tuesday, June 30th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend is Friday, June 19th. This is a boost from UnitedHealth Group's previous quarterly dividend of $1.08. View UnitedHealth Group's dividend history.

What guidance has UnitedHealth Group issued on next quarter's earnings?

UnitedHealth Group issued an update on its FY20 earnings guidance on Wednesday, April, 15th. The company provided earnings per share (EPS) guidance of $16.25-16.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $16.22.

What price target have analysts set for UNH?

23 equities research analysts have issued 1 year price objectives for UnitedHealth Group's stock. Their forecasts range from $235.00 to $384.00. On average, they expect UnitedHealth Group's stock price to reach $325.59 in the next year. This suggests a possible upside of 4.4% from the stock's current price. View analysts' price targets for UnitedHealth Group.

Has UnitedHealth Group been receiving favorable news coverage?

News headlines about UNH stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. UnitedHealth Group earned a news impact score of 1.0 on InfoTrie's scale. They also gave news stories about the healthcare conglomerate a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutUnitedHealth Group.

Which major investors are selling UnitedHealth Group stock?

UNH stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Capital International Investors, Johanson Financial Advisors Inc., Janus Henderson Group PLC, Nuveen Asset Management LLC, 1832 Asset Management L.P., Clearbridge Investments LLC, and California Public Employees Retirement System. Company insiders that have sold UnitedHealth Group company stock in the last year include D Ellen Wilson, Richard T Burke, Stephen J Hemsley, Thomas E Roos, and William C Ballard Jr. View insider buying and selling activity for UnitedHealth Group.

Which major investors are buying UnitedHealth Group stock?

UNH stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Franklin Resources Inc., Swiss National Bank, Girard Partners LTD., Eaton Vance Management, APG Asset Management N.V., Advisor Group Holdings Inc., and Lone Pine Capital LLC. Company insiders that have bought UnitedHealth Group stock in the last two years include David S Wichmann, Frederick William Mcnabb III, and Timothy Patrick Flynn. View insider buying and selling activity for UnitedHealth Group.

How do I buy shares of UnitedHealth Group?

Shares of UNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is UnitedHealth Group's stock price today?

One share of UNH stock can currently be purchased for approximately $311.85.

How big of a company is UnitedHealth Group?

UnitedHealth Group has a market capitalization of $295.75 billion and generates $242.16 billion in revenue each year. The healthcare conglomerate earns $13.84 billion in net income (profit) each year or $15.11 on an earnings per share basis. UnitedHealth Group employs 325,000 workers across the globe.